Patrick C. Roche
- Oncology top 0.1%
- HER2/EGFR in Cancer Research 20
- Cancer-related Molecular Pathways 7
- Immunology top 0.5%
- Pathology and Forensic Medicine top 0.2%
- Genetic factors in colorectal cancer 10
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 8
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 10
-
- Monoclonal and Polyclonal Antibodies Research 20
-
- Advanced Biosensing Techniques and Applications 14
-
- Sarcoma Diagnosis and Treatment 8
Patrick C. Roche
141 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Oncology 7.7k
- Immunology 4.2k
- Pathology and Forensic Medicine 2.7k
- Cancer Research 2.0k
- Reproductive Medicine 668
Countries citing papers authored by Patrick C. Roche
This map shows the geographic impact of Patrick C. Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Roche more than expected).
Fields of papers citing papers by Patrick C. Roche
This network shows the impact of papers produced by Patrick C. Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Roche. The network helps show where Patrick C. Roche may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick C. Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 16 | |
| 2 | 2006 | 28 | |
| 3 | Clinical laboratory assays for HER-2/neu amplification and overexpression: Quality assurance, standardization, and proficiency testing | 2002 | 65 |
| 4 | 2002 | 39 | |
| 5 | 2002 | 248 | |
| 6 | Utilization of gene expression profiling to identify markers of disease recurrence in node-negative breast cancer | 2001 | 1 |
| 7 | Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000) | 2000 | 3 |
| 8 | 2000 | 24 | |
| 9 | 2000 | 37 | |
| 10 | 1999 | 93 | |
| 11 | 1998 | 137 | |
| 12 | 1998 | 110 | |
| 13 | 1998 | 113 | |
| 14 | Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinomabreakdown → | 1998 | 541 |
| 15 | 1997 | 4 | |
| 16 | 1996 | 97 | |
| 17 | 1996 | 21 | |
| 18 | 1995 | 59 | |
| 19 | 1995 | 20 | |
| 20 | 1994 | 73 |
About Patrick C. Roche
Patrick C. Roche is a scholar working on Reproductive Medicine, Oncology and Pathology and Forensic Medicine, having authored 142 papers that have together received 15.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (20 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Advanced Biosensing Techniques and Applications (14 papers), Genetic factors in colorectal cancer (10 papers), Ovarian cancer diagnosis and treatment (10 papers), Cancer Genomics and Diagnostics (8 papers), Sarcoma Diagnosis and Treatment (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Oncology (7.7k citations), Immunology (4.2k citations) and Pathology and Forensic Medicine (2.7k citations). Patrick C. Roche has collaborated with scholars based in United States, Ireland and Australia. Frequent co-authors include Esteban Celis, Scott E. Strome, Lieping Chen, Hideto Tamura, Fumiya Hirano, Koji Tamada, Vanda A. Lennon, Jun Lü, Gefeng Zhu and Dallas B. Flies. Their work appears in journals such as Gynecologic Oncology, Endocrinology, The American Journal of Surgical Pathology, Mayo Clinic Proceedings and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.